Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Okamoto

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmunology|June 10, 2011
Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroidsLara Sanvito, Atsuko Tomita, Norio Chihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis opticaNorio Chihara, Toshimasa Aranami, Wakiro Sato, et al.
Neuroradiology|April 21, 2010
Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficientYuko Adachi, Noriko Sato, Tomoko Okamoto, et al.
BMJ Neurology Open|June 17, 2024
'Grasshopper sign': the novel imaging of post-COVID-19 myelopathy with delayed longitudinal white matter abnormalitiesMotohiro Okumura, Kazumasa Sekiguchi, Tomoko Okamoto, et al.
Neurology|March 18, 2014
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot studyManabu Araki, Takako Matsuoka, Katsuichi Miyamoto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2024
CD11c<sup>high</sup> B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis OpticaEiichiro Amano, Wakiro Sato, Yukio Kimura, et al.
Research in Veterinary Science|April 11, 2025
Prognostic value of circulating cardiac and renal biomarkers in dogs with myxomatous mitral valve diseaseNaoki Iwasa, Rie Kumazawa, Mamu Shimizu, et al.
Annals of Neurology|August 23, 2021
Th1 - CD11c<sup>+</sup> B Cell Axis Associated with Response to Plasmapheresis in Multiple SclerosisKimitoshi Kimura, Youwei Lin, Hiromi Yamaguchi, et al.
JMIR Research Protocols|January 15, 2024
Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical TrialTomoko Okamoto, Takami Ishizuka, Reiko Shimizu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2023
Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum DisorderTakako Matsuoka, Manabu Araki, Youwei Lin, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmunology|June 10, 2011
Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroidsLara Sanvito, Atsuko Tomita, Norio Chihara, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2011
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis opticaNorio Chihara, Toshimasa Aranami, Wakiro Sato, et al.
Neuroradiology|April 21, 2010
Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficientYuko Adachi, Noriko Sato, Tomoko Okamoto, et al.
BMJ Neurology Open|June 17, 2024
'Grasshopper sign': the novel imaging of post-COVID-19 myelopathy with delayed longitudinal white matter abnormalitiesMotohiro Okumura, Kazumasa Sekiguchi, Tomoko Okamoto, et al.
Neurology|March 18, 2014
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot studyManabu Araki, Takako Matsuoka, Katsuichi Miyamoto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2024
CD11c<sup>high</sup> B Cell Expansion Is Associated With Severity and Brain Atrophy in Neuromyelitis OpticaEiichiro Amano, Wakiro Sato, Yukio Kimura, et al.
Research in Veterinary Science|April 11, 2025
Prognostic value of circulating cardiac and renal biomarkers in dogs with myxomatous mitral valve diseaseNaoki Iwasa, Rie Kumazawa, Mamu Shimizu, et al.
Annals of Neurology|August 23, 2021
Th1 - CD11c<sup>+</sup> B Cell Axis Associated with Response to Plasmapheresis in Multiple SclerosisKimitoshi Kimura, Youwei Lin, Hiromi Yamaguchi, et al.
JMIR Research Protocols|January 15, 2024
Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical TrialTomoko Okamoto, Takami Ishizuka, Reiko Shimizu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2023
Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum DisorderTakako Matsuoka, Manabu Araki, Youwei Lin, et al.
Pageof 8